139 related articles for article (PubMed ID: 10776080)
1. Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.
Vogel S; Schweitzer S; Seiler S
ANNA J; 1999 Oct; 26(5):515-21. PubMed ID: 10776080
[TBL] [Abstract][Full Text] [Related]
2. Benefits of early utilization of intravenous iron.
Vogel S
Nephrol Nurs J; 2000 Feb; 27(1):61-5. PubMed ID: 10852693
[TBL] [Abstract][Full Text] [Related]
3. Addressing patient concerns about intravenous iron therapy.
Robbins KC
Nephrol Nurs J; 2003 Apr; 30(2):220-4, 258. PubMed ID: 12737000
[TBL] [Abstract][Full Text] [Related]
4. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
[TBL] [Abstract][Full Text] [Related]
5. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
Faich G; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):464-70. PubMed ID: 10070910
[TBL] [Abstract][Full Text] [Related]
6. Anemia management: recognizing opportunities and improving outcomes through nursing interventions.
Lewis M; Wick GS; Foret J
Nephrol Nurs J; 2000 Oct; 27(5):507-12. PubMed ID: 16649326
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
Kaskel FJ
Nat Clin Pract Nephrol; 2006 May; 2(5):244-5. PubMed ID: 16932433
[No Abstract] [Full Text] [Related]
8. Parenteral iron use in the management of anemia in end-stage renal disease patients.
Bailie GR; Johnson CA; Mason NA
Am J Kidney Dis; 2000 Jan; 35(1):1-12. PubMed ID: 10620537
[TBL] [Abstract][Full Text] [Related]
9. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
Warady BA; Zobrist RH; Wu J; Finan E;
Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
[TBL] [Abstract][Full Text] [Related]
10. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
Brookhart MA; Freburger JK; Ellis AR; Winkelmayer WC; Wang L; Kshirsagar AV
Am J Kidney Dis; 2016 Jan; 67(1):119-27. PubMed ID: 26385819
[TBL] [Abstract][Full Text] [Related]
11. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
Folkert VW; Michael B; Agarwal R; Coyne DW; Dahl N; Myirski P; Warnock DG;
Am J Kidney Dis; 2003 Mar; 41(3):651-7. PubMed ID: 12612989
[TBL] [Abstract][Full Text] [Related]
12. Implementing continuous quality improvement strategies for improving iron replacement in hemodialysis patients.
Trenkle JA
Nephrol Nurs J; 2001 Oct; 28(5):561-5. PubMed ID: 12143432
[TBL] [Abstract][Full Text] [Related]
13. Anemia of chronic renal failure: new treatment alternative.
Seiler S
CANNT J; 2000; 10(3):35-9, 43-8; quiz 40-2, 49-51. PubMed ID: 11799582
[TBL] [Abstract][Full Text] [Related]
14. Safety profile of a high dose ferric gluconate in patients with severe chronic renal insufficiency.
Jain AK; Bastani B
J Nephrol; 2002; 15(6):681-3. PubMed ID: 12495284
[TBL] [Abstract][Full Text] [Related]
15. Intravenous iron products.
Johnson CA; Mason NA; Bailie GR
ANNA J; 1999 Oct; 26(5):522-4. PubMed ID: 10776081
[TBL] [Abstract][Full Text] [Related]
16. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
Easom A
Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
[TBL] [Abstract][Full Text] [Related]
17. Updating practices in an evolving IV iron and anemia environment: practical solutions.
Amerling R; Easom A; Juergensen P
Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
[TBL] [Abstract][Full Text] [Related]
18. Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.
Fishbane S; Wagner J
Am J Kidney Dis; 2001 May; 37(5):879-83. PubMed ID: 11325667
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
20. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
Sane R; Baribeault D; Rosenberg CL
Pharmacotherapy; 2007 Apr; 27(4):613-5. PubMed ID: 17381390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]